Risk Factors and Medical Management of Vasospasm After Subarachnoid Hemorrhage

Neurosurgery Clinics of North America

Volumn 21, Issue 2, 2010, Pages 353-364

  Lazaridis, Christos ^a   Naval, Neeraj ^b,c  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Aneurysmal subarachnoid hemorrhage; Cerebral blood flow; Triple H therapy; Vasospasm

Indexed keywords

ACETYLSALICYLIC ACID; CLAZOSENTAN; DOBUTAMINE; DOPAMINE; FLUDROCORTISONE; GLYCERYL TRINITRATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPERTENSIVE FACTOR; INOTROPIC AGENT; LOW MOLECULAR WEIGHT HEPARIN; MAGNESIUM; MILRINONE; NEUROPROTECTIVE AGENT; NIMODIPINE; NITRIC OXIDE DONOR; NORADRENALIN; PHENYLEPHRINE; PLACEBO; SIMVASTATIN; TIRILAZAD; XENON 133;

ANGIOGRAPHY; BRAIN VASOSPASM; CLINICAL TRIAL; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTINUOUS INFUSION; DOPPLER ECHOGRAPHY; DRUG WITHDRAWAL; HUMAN; HYPONATREMIA; MORBIDITY; MORTALITY; NEUROPROTECTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SUBARACHNOID HEMORRHAGE; VASOSPASM;

CEREBRAL ANGIOGRAPHY; CEREBRAL ARTERIES; CEREBROVASCULAR CIRCULATION; DIAGNOSTIC IMAGING; HUMANS; NEUROPROTECTIVE AGENTS; RISK FACTORS; SUBARACHNOID HEMORRHAGE; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL; VASOSPASM, INTRACRANIAL;

EID: 77951050558     PISSN: 10423680     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nec.2009.10.006     Document Type: Review

References (111)

1. Graf C.J., Nibbelink D.W. Cooperative study of intracranial aneurysms and subarachnoid hemorrhage: report on a randomized treatment study, 3: intracranial surgery. Stroke 1974, 5:557-601.
2. King J.T. Epidemiology of aneurysmal subarachnoid hemorrhage. Neuroimaging Clin N Am 1997, 7:659-668.
3. Anderson C., Anderson N., Bonita R., et al. Epidemiology of aneurysmal subarachnoid hemorrhage in Australia and New Zealand: incidence and case fatality from the Australasian Cooperative Research on Subarachnoid Hemorrhage Study (ACROSS). Stroke 2000, 31:1843-1850.
4. Johnston S.C., Selvin S., Gress D.R. The burden, trends, and demographics of mortality from subarachnoid hemorrhage. Neurology 1998, 50:1413-1418.
5. Huang J., Van Gelder J.M. The probability of sudden death from rupture of intracranial aneurysms: a meta-analysis. Neurosurgery 2002, 51:1101-1105.
6. Schievink W.I. Intracranial aneurysms. N Engl J Med 1997, 336:28-40.
7. Kassell N.F., Torner J.C. Aneurysmal rebleeding: a preliminary report from the Cooperative Aneurysm Study. Neurosurgery 1983, 13:479-481.
8. Ohkuma H., Tsurutani H., Suzuki S. Incidence and significance of early aneurysmal rebleeding before neurosurgical or neurological management. Stroke 2001, 32:1176-1180.
9. Hillman J., Fridriksson S., Nilsson O., et al. Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: a prospective randomized study. J Neurosurg 2002, 97:771-778.
10. Starke R.M., Kim G.H., Fernandez A., et al. Impact of a protocol for acute antifibrinolytic therapy on aneurysm rebleeding after subarachnoid hemorrhage. Stroke 2008, 39:2617-2621.
11. Cahill J., Calvert J.W., Zhang J.H. Mechanisms of early brain injury after subarachnoid hemorrhage. J Cereb Blood Flow Metab 2006, 26(11):1341-1353.
12. Cahill J., Zhang J.H. Subarachnoid hemorrhage: is it time for a new direction?. Stroke 2009, 40(Suppl 3):S86-S87.
13. Eddleman C.S., Hurley M.C., Naidech A.M., et al. Endovascular options in the treatment of delayed ischemic neurological deficits due to cerebral vasospasm. Neurosurg Focus 2009, 26(3):E6.
14. Rinkel G., Feigin V., Algra A., et al. Circulatory volume expansion therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 2004, (4). CD000483.
15. Pluta R.M., Hansen-Schwartz J., Dreier J., et al. Cerebral vasospasm following subarachnoid hemorrhage: time for a new world of thought. Neurol Res 2009, 31(2):151-158.
16. Vergouwen M.D., Vermeulen M., Coert B.A., et al. Delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: is angiographic vasospasm an epiphenomenon?. Stroke 2009, 40(2):e39.
17. Vergouwen M.D., Vermeulen M., Coert B.A., et al. Microthrombosis after aneurysmal subarachnoid hemorrhage: an additional explanation for delayed cerebral ischemia. J Cereb Blood Flow Metab 2008, 28(11):1761-1770.
18. Stein S.C., Levine J.M., Nagpal S., et al. Vasospasm as the sole cause of cerebral ischemia: how strong is the evidence? [review]. Neurosurg Focus 2006, 21(3):E2.
19. Dorsch N.W. Cerebral arterial spasm-a clinical review. Br J Neurosurg 1995, 9:403-412.
20. Heros R.C., Zervas N.T., Varsos V. Cerebral vasospasm after subarachnoid hemorrhage: an update. Ann Neurol 1983, 14:599-608.
21. Baldwin M.E., Macdonald R.L., Huo D., et al. Early vasospasm on admission angiography in patients with aneurysmal subarachnoid hemorrhage is a predictor for in-hospital complications and poor outcome. Stroke 2004, 35:2506-2511.
22. Qureshi A.I., Sung G.Y., Suri M.A., et al. Prognostic value and determinants of ultraearly angiographic vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery 1999, 44:967-974.
23. Kolias A.G., Sen J., Belli A.J. Pathogenesis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage: putative mechanisms and novel approaches. Neurosci Res 2009, 87(1):1-11.
24. Macdonald R.L., Weir B.K. A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke 1991, 22:971-982.
25. Fisher C.M., Kistler J.P., Davis J.M. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 1980, 6:1-9.
26. Claassen J., Bernardini G.L., Kreiter K., et al. Effect of cisternal and ventricular blood on risk of delayed cerebral ischemia after subarachnoid hemorrhage: the Fisher scale revisited. Stroke 2001, 32:2012-2020.
27. Frontera J.A., Claassen J., Schmidt J.M., et al. Prediction of symptomatic vasospasm after subarachnoid hemorrhage: the modified fisher scale. Neurosurgery 2006, 59:21-27.
28. Amin-Hanjani S., Ogilvy C.S., Barker F.G. Does intracisternal thrombolysis prevent vasospasm after aneurysmal subarachnoid hemorrhage? A meta-analysis. Neurosurgery 2004, 54:326-334.
29. Kawamoto S., Tsutsumi K., Yoshikawa G., et al. Effectiveness of the head-shaking method combined with cisternal irrigation with urokinase in preventing cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg 2004, 100:236-243.
30. Klimo P., Kestle J.R., MacDonald J.D., et al. Marked reduction of cerebral vasospasm with lumbar drainage of cerebrospinal fluid after subarachnoid hemorrhage. J Neurosurg 2004, 100:215-224.
31. Rabb C.H., Tang G., Chin L.S., et al. A statistical analysis of factors related to symptomatic cerebral vasospasm. Acta Neurochir 1994, 127:27-31.
32. Lasner T.M., Weil R.J., Riina H.A., et al. Cigarette smoking-induced increase in the risk of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage. J Neurosurg 1997, 87(3):381-384.
33. Inagawa T. Cerebral vasospasm in elderly patients treated by early operation for ruptured intracranial aneurysms. Acta Neurochir 1992, 115:79-85.
34. Wijdicks E.F.M., Vermeulen M., ten Haaf J.A., et al. Volume depletion and natriuresis in patients with a ruptured intracranial aneurysm. Ann Neurol 1985, 18:211-216.
35. Bederson J.B., Connolly E.S., Batjer H.H., et al. American Heart Association Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 2009, 40(3):994-1025.
36. Lennihan L., Mayer S.A., Fink M.E., et al. Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage: a randomized controlled trial. Stroke 2000, 31:383-391.
37. Egge A., Waterloo K., Sjoholm H., et al. Prophylactic hyperdynamic postoperative fluid therapy after aneurismal subarachnoid hemorrhage: a clinical, prospective, randomized, controlled study. Neurosurgery 2001, 49:593-605.
38. van der Bilt I.A., Hasan D., Vandertop W.P., et al. Impact of cardiac complications on outcome after aneurysmal subarachnoid hemorrhage: a meta-analysis. Neurology 2009, 72(7):635-642.
39. Fujita K., Fukuhara T., Munemasa M., et al. Ampulla cardiomyopathy associated with aneurysmal subarachnoid hemorrhage: report of 6 patients. Surg Neurol 2007, 68(5):556-561.
40. Muroi C., Keller M., Pangalu A., et al. Neurogenic pulmonary edema in patients with subarachnoid hemorrhage. J Neurosurg Anesthesiol 2008, 20(3):188-192.
41. Corsten L., Raja A., Guppy K., et al. Contemporary management of subarachnoid hemorrhage and vasospasm: the UIC experience. Surg Neurol 2001, 56(3):140-148.
42. Mascia L., Sakr Y., Pasero D., et al. Sepsis Occurrence in Acutely Ill Patients (SOAP) Investigators Extracranial complications in patients with acute brain injury: a post-hoc analysis of the SOAP study. Intensive Care Med 2008, 34(4):720-727.
43. Vincent J.L., Sakr Y., Sprung C.L., et al. Sepsis Occurrence in Acutely Ill Patients Investigators Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 2006, 34(2):344-353.
44. Kasuya H., Onda H., Yoneyama T., et al. Bedside monitoring of circulating blood volume after subarachnoid hemorrhage. Stroke 2003, 34(4):956-960.
45. Hoff R.G., van Dijk G.W., Algra A., et al. Fluid balance and blood volume measurement after aneurysmal subarachnoid hemorrhage. Neurocrit Care 2008, 8(3):391-397.
46. Kumar A., Anel R., Bunnell E., et al. Pulmonary artery occlusion pressure and central venous pressure fail to predict ventricular filling volume, cardiac performance, or the response to volume infusion in normal subjects. Crit Care Med 2004, 32(3):691-699.
47. Osman D., Ridel C., Ray P., et al. Cardiac filling pressures are not appropriate to predict hemodynamic response to volume challenge. Crit Care Med 2007, 35(1):64-68.
48. Michard F., Boussat S., Chemla D., et al. Relation between respiratory changes in arterial pulse pressure and fluid responsiveness in septic patients with acute circulatory failure. Am J Respir Crit Care Med 2000, 162(1):134-138.
49. Gödje O., Höke K., Goetz A.E., et al. Reliability of a new algorithm for continuous cardiac output determination by pulse-contour analysis during hemodynamic instability. Crit Care Med 2002, 30(1):52-58.
50. Spöhr F., Hettrich P., Bauer H., et al. Comparison of two methods for enhanced continuous circulatory monitoring in patients with septic shock. Intensive Care Med 2007, 33(10):1805-1810.
51. Friesecke S., Heinrich A., Abel P., et al. Comparison of pulmonary artery and aortic transpulmonary thermodilution for monitoring of cardiac output in patients with severe heart failure: validation of a novel method. Crit Care Med 2009, 37(1):119-123.
52. Berkowitz D.M., Danai P.A., Eaton S., et al. Accurate characterization of extravascular lung water in acute respiratory distress syndrome. Crit Care Med 2008, 36(6):1803-1809.
53. Segal E., Greenlee J.D., Hata S.J., et al. Monitoring intravascular volumes to direct hypertensive, hypervolemic therapy in a patient with vasospasm. J Neurosurg Anesthesiol 2004, 16:296-298.
54. Mutoh T., Kazumata K., Ajiki M., et al. Goal-directed fluid management by bedside transpulmonary hemodynamic monitoring after subarachnoid hemorrhage. Stroke 2007, 38(12):3218-3224.
55. Muench E., Horn P., Bauhuf C., et al. Effects of hypervolemia and hypertension on regional cerebral blood flow, intracranial pressure, and brain tissue oxygenation after subarachnoid hemorrhage. Crit Care Med 2007, 35(8):1844-1851.
56. Naval N.S., Stevens R.D., Mirski M.A., et al. Controversies in the management of aneurysmal subarachnoid hemorrhage [review]. Crit Care Med 2006, 34(2):511-524.
57. Hasan D., Lindsay K.W., Wijdicks E.F., et al. Effect of fludrocortisone acetate in patients with subarachnoid hemorrhage. Stroke 1989, 20:1156-1161.
58. Mori T., Katayama Y., Kawamata T., et al. Improved efficiency of hypervolemic therapy with inhibition of natriuresis by fludrocortisone in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 1999, 91:947-952.
59. Mayer S.A., Solomon R.A., Fink M.E., et al. Effect of 5% albumin solution on sodium balance and blood volume after subarachnoid hemorrhage. Neurosurgery 1998, 42:759-767.
60. Pickard J.D., Murray G.D., Illingworth R., et al. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ 1989, 298:636-642.
61. Rinkel G.J.E., Feigin V.L., Algra A., et al. Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 2005, (1). CD000277.
62. Zubkov A.Y., Rabinstein A.A. Medical management of cerebral vasospasm: present and future. Neurol Res 2009, 31(6):626-631.
63. Feigin V.L., Rinkel G.J., Algra A., et al. Calcium antagonists in patients with aneurismal subarachnoid hemorrhage: a systematic review. Neurology 1998, 50:876-883.
64. Roos Y.B., Levi M., Carroll T.A., et al. Nimodipine increases fibrinolytic activity in patients with aneurysmal subarachnoid hemorrhage. Stroke 2001, 32:1860-1862.
65. Dreier J.P., Körner K., Ebert N., et al. Nitric oxide scavenging by hemoglobin or nitric oxide synthase inhibition by N-nitro-L-arginine induces cortical spreading ischemia when K+ is increased in the subarachnoid space. J Cereb Blood Flow Metab 1998, 18:978-990.
66. Sillberg V.A., Wells G.A., Perry J.J. Do statins improve outcomes and reduce the incidence of vasospasm after aneurysmal subarachnoid hemorrhage: a meta-analysis. Stroke 2008, 39(9):2622-2626.
67. Kramer A.H., Gurka M.J., Nathan B., et al. Statin use was not associated with less vasospasm or improved outcome after subarachnoid hemorrhage. Neurosurgery 2008, 62(2):422-427. [discussion: 427-30].
68. McGirt M.J., Garces Ambrossi G.L., Huang J., et al. Simvastatin for the prevention of symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage: a single-institution prospective cohort study. J Neurosurg 2009, 110(5):968-974.
69. Macdonald R.L., Kassell N.F., Mayer S., et al. CONSCIOUS-1 Investigators Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Stroke 2008, 39(11):3015-3021.
70. Pearl J.D., Macdonald R.L. Vasospasm after aneurysmal subarachnoid hemorrhage: need for further study. Acta Neurochir Suppl 2008, 105:207-210.
71. Jang Y.G., Ilodigwe D., Macdonald R.L. Metaanalysis of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage. Neurocrit Care 2009, 10(1):141-147.
72. van den Bergh W.M., Algra A., van Kooten F., et al. MASH Study Group Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial. Stroke 2005, 36(5):1011-1015.
73. Dorhout Mees S.M., MASH-II Study Group Magnesium in aneurysmal subarachnoid hemorrhage (MASH II) phase III clinical trial MASH-II study group. Int J Stroke 2008, 3(1):63-65.
74. Rabinstein A.A., Friedman J.A., Weigand S.D., et al. Predictors of cerebral infarction in aneurysmal subarachnoid hemorrhage. Stroke 2004, 35:1862-1866.
75. Sloan M.A., Alexandrov A.V., Tegeler C.H., et al. Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Assessment: transcranial Doppler ultrasonography: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2004, 62:1468-1481.
76. Lysakowski C., Walder B., Costanza M.C., et al. Transcranial Doppler versus angiography in patients with vasospasm due to a ruptured cerebral aneurysm: a systematic review. Stroke 2001, 32:2292-2298.
77. Minhas P.S., Menon D.K., Smielewski P., et al. Positron emission tomographic cerebral perfusion disturbances and transcranial Doppler findings among patients with neurological deterioration after subarachnoid hemorrhage. Neurosurgery 2003, 52(5):1017-1022.
78. Lam J.M., Smielewski P., Czosnyka M., et al. Predicting delayed ischemic deficits after aneurysmal subarachnoid hemorrhage using a transient hyperemic response test of cerebral autoregulation. Neurosurgery 2000, 47:819-826.
79. Rätsep T., Asser T. Cerebral hemodynamic impairment after aneurysmal subarachnoid hemorrhage as evaluated using transcranial Doppler ultrasonography: relationship to delayed cerebral ischemia and clinical outcome. J Neurosurg 2001, 95:393-401.
80. Soehle M., Czosnyka M., Pickard J.D., et al. Continuous assessment of cerebral autoregulation in subarachnoid hemorrhage. Anesth Analg 2004, 98(4):1133-1139.
81. Tseng M.Y., Czosnyka M., Richards H., et al. Effects of acute treatment with statins on cerebral autoregulation in patients after aneurysmal subarachnoid hemorrhage. Neurosurg Focus 2006, 21(3):E10.
82. Jaeger M., Schuhmann M.U., Soehle M., et al. Continuous monitoring of cerebrovascular autoregulation after subarachnoid hemorrhage by brain tissue oxygen pressure reactivity and its relation to delayed cerebral infarction. Stroke 2007, 38(3):981-986.
83. Bellander B.M., Cantais E., Enblad P., et al. Consensus meeting on microdialysis in neurointensive care. Intensive Care Med 2004, 30(12):2166-2169.
84. Sarrafzadeh A., Haux D., Plotkin M., et al. Bedside microdialysis reflects dysfunction of cerebral energy metabolism in patients with aneurysmal subarachnoid hemorrhage as confirmed by 15 O-H2 O-PET and 18 F-FDG-PET. J Neuroradiol 2005, 32(5):348-351.
85. Unterberg A.W., Sakowitz O.W., Sarrafzadeh A.S., et al. Role of bedside microdialysis in the diagnosis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 2001, 94:740-749.
86. Ramakrishna R., Stiefel M., Udoetuk J., et al. Brain oxygen tension and outcome in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 2008, 109(6):1075-1082.
87. Lad S.P., Guzman R., Kelly M.E., et al. Cerebral perfusion imaging in vasospasm [review]. Neurosurg Focus 2006, 21(3):E7.
88. Laslo A.M., Eastwood J.D., Pakkiri P., et al. CT perfusion-derived mean transit time predicts early mortality and delayed vasospasm after experimental subarachnoid hemorrhage. AJNR Am J Neuroradiol 2008, 29(1):79-85.
89. Pham M., Johnson A., Bartsch A.J., et al. CT perfusion predicts secondary cerebral infarction after aneurysmal subarachnoid hemorrhage. Neurology 2007, 69(8):762-765.
90. Sviri G.E., Mesiwala A.H., Lewis D.H., et al. Dynamic perfusion computerized tomography in cerebral vasospasm following aneurysmal subarachnoid hemorrhage: a comparison with technetium-99m-labeled ethyl cysteinate dimer-single-photon emission computerized tomography. J Neurosurg 2006, 104(3):404-410.
91. Kosnik E.J., Hunt W.E. Postoperative hypertension in the management of patients with intracranial arterial aneurysms. J Neurosurg 1976, 45(2):148-154.
92. Kassell N.F., Peerless S.J., Durward Q.J., et al. Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension. Neurosurgery 1982, 11(3):337-343.
93. Treggiari M.M., Walder B., Suter P.M., et al. Systematic review of the prevention of delayed ischemic neurological deficits with hypertension, hypervolemia, and hemodilution therapy following subarachnoid hemorrhage [review]. J Neurosurg 2003, 98(5):978-984.
94. Jost S.C., Diringer M.N., Zazulia A.R., et al. Effect of normal saline bolus on cerebral blood flow in regions with low baseline flow in patients with vasospasm following subarachnoid hemorrhage. J Neurosurg 2005, 103(1):25-30.
95. Tseng M.Y., Al-Rawi P.G., Czosnyka M., et al. Enhancement of cerebral blood flow using systemic hypertonic saline therapy improves outcome in patients with poor-grade spontaneous subarachnoid hemorrhage. J Neurosurg 2007, 107(2):274-282.
96. Ekelund A., Reinstrup P., Ryding E., et al. Effects of iso- and hypervolemic hemodilution on regional cerebral blood flow and oxygendelivery for patients with vasospasm after aneurysmal subarachnoid hemorrhage. Acta Neurochir (Wien) 2002, 144:703-712.
97. Kramer A.H., Gurka M.J., Nathan B., et al. Complications associated with anemia and blood transfusion in patients with aneurysmal subarachnoid hemorrhage. Crit Care Med 2008, 36(7):2070-2075.
98. Naidech A.M., Jovanovic B., Wartenberg K.E., et al. Higher hemoglobin is associated with improved outcome after subarachnoid hemorrhage. Crit Care Med 2007, 35(10):2383-2389.
99. Oddo M., Milby A., Chen I., et al. Hemoglobin concentration and cerebral metabolism in patients with aneurysmal subarachnoid hemorrhage. Stroke 2009, 40(4):1275-1281.
100. Miller J.A., Dacey R.G., Diringer M.N. Safety of hypertensive hypervolemic therapy with phenylephrine in the treatment of delayed ischemic deficits after subarachnoid hemorrhage. Stroke 1995, 26(12):2260-2266.
101. Johnston A.J., Steiner L.A., Chatfield D.A., et al. Effect of cerebral perfusion pressure augmentation with dopamine and norepinephrine on global and focal brain oxygenation after traumatic brain injury. Intensive Care Med 2004, 30(5):791-797.
102. Steiner L.A., Johnston A.J., Czosnyka M., et al. Direct comparison of cerebrovascular effects of norepinephrine and dopamine in head-injured patients. Crit Care Med 2004, 32(4):1049-1054.
103. Kim H.D., Joseph M., Ziadi S., et al. Increases in cardiac output can reverse flow deficits from vasospasm independent of blood pressure: a study using xenon computed tomographic measurement of cerebral blood flow. Neurosurgery 2003, 53(5):1044-1051.
104. Naidech A., Du Y., Kreiter K.T., et al. Dobutamine versus milrinone after subarachnoid hemorrhage. Neurosurgery 2005, 56(1):21-26.
105. Lee V.H., Connolly H.M., Fulgham J.R., et al. Tako-tsubo cardiomyopathy in aneurysmal subarachnoid hemorrhage: an underappreciated ventricular dysfunction. J Neurosurg 2006, 105(2):264-270.
106. Kawai S., Kitabatake A., Tomoike H., Takotsubo Cardiomyopathy Group Guidelines for diagnosis of takotsubo (ampulla) cardiomyopathy. Circ J 2007, 71(6):990-992.
107. Apostolides P.J., Greene K.A., Zabramski J.M., et al. Intra-aortic balloon pump counterpulsation in the management of concomitant cerebral vasospasm and cardiac failure after subarachnoid hemorrhage: technical case report. Neurosurgery 1996, 38(5):1056-1059. [discussion: 1059-60].
108. Rosen C.L., Sekhar L.N., Duong D.H. Use of intra-aortic balloon pump counterpulsation for refractory symptomatic vasospasm. Acta Neurochir (Wien) 2000, 142(1):25-32.
109. Tung P., Kopelnik A., Banki N., et al. Predictors of neurocardiogenic injury after subarachnoid hemorrhage. Stroke 2004, 35(2):548-551.
110. Wittstein I.S., Thiemann D.R., Lima J.A., et al. Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med 2005, 352(6):539-548.
111. Spann R.G., Lang D.A., Birch A.A., et al. Intra-aortic balloon counterpulsation: augmentation of cerebral blood flow after aneurysmal subarachnoid haemorrhage. Acta Neurochir (Wien) 2001, 143(2):115-123.